Common mucosal immunity plays an important role in host protection against infectious diseases. Secretory immunoglobulins reduce microbial and viral growth, and decrease adherence and colonization of microorganisms to host mucosal sites. Our studies indicate that the skin can serve as an effective site for the induction of common mucosal immunity under certain circumstances. We have demonstrated that the subcutaneous immunization of naive animals with an antigen plus alpha,25(OH)2d3 induces both common mucosal and systemic immune responses. Peyer's patches are the primary lymphoid organ inductive site for these skin-induced mucosal responses, identical to what occurs following an oral immunization. This was deduced by analysis of germinal center development and lymphoid tissue sites of antibody producing cells. We recently found that dendritic cells (DC) pulsed with antigen and treated with 1alpha,25(OH)2d3, induced mucosal and systemic immune responses following their injection into footpads of naive recipients. Our objectives are now to examine those conditions which are essential for the induction of mucosal and systemic immune responses following the administration of antigen-pulsed DC to immunologically naive recipients. We will investigate whether antigen-pulsed DC can effectively promote germinal center development in classical mucosal immunity inductive sites following their pretreatment with 1alpha,25(OH)2D3, and determine how such treatments alter the homing properties of the injected cells. We will evaluate if such enzyme induction may represent a natural way to promote mucosal immunity to antigens delivered via the skin. Newborns and the elderly are highly susceptible to gastrointestinal and respiratory diseases normally controlled by mucosal defenses. We will study the protective properties in offspring of passively acquired induced in mothers by systemic immunization with antigens plus 1alpha,25(OH)2D3. We will also investigate intervention strategies which restore mucosal immune competence to aged animals. Our studies could uncover novel characteristics about the mammalian immune system and its flexibility in regulating particular forms of effector responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK055491-04
Application #
6517570
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Hamilton, Frank A
Project Start
1999-05-01
Project End
2004-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
4
Fiscal Year
2002
Total Cost
$245,276
Indirect Cost
Name
University of Utah
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Enioutina, Elena Y; Bareyan, Diana; Daynes, Raymond A (2008) TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 26:601-13
Enioutina, Elena Y; Bareyan, Diana; Daynes, Raymond A (2007) Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine 25:1236-49
Zhang, Tian Y; Daynes, Raymond A (2007) Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway. J Immunol 178:2517-26
Zhang, Tian Y; Ding, Xiaohong; Daynes, Raymond A (2005) The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. J Immunol 174:879-89
Jones, Dallas C; Ding, Xiaohong; Zhang, Tian Y et al. (2003) Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation. J Immunol 171:196-203
Daynes, Raymond A; Enioutina, Elena Y; Jones, Dallas C (2003) Role of redox imbalance in the molecular mechanisms responsible for immunosenescence. Antioxid Redox Signal 5:537-48
Enioutina, Elena Y; Visic, Dino M; Daynes, Raymond A (2002) The induction of systemic and mucosal immunity to protein vaccines delivered through skin sites exposed to UVB. Vaccine 20:2116-30
Jones, Dallas C; Manning, Bernadette M; Daynes, Raymond A (2002) A role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology. Proc Nutr Soc 61:363-9
Jones, Dallas C; Ding, Xiaohong; Daynes, Raymond A (2002) Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 277:6838-45
Heithoff, D M; Enioutina, E Y; Daynes, R A et al. (2001) Salmonella DNA adenine methylase mutants confer cross-protective immunity. Infect Immun 69:6725-30

Showing the most recent 10 out of 15 publications